All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2005-002463-88 | Efficacy and safety of a human normal immunoglobulin product for intravenous administration (IVIg) in the treatment of dermatomyositis (DM) and polymyositis (PM): prospective, randomised, double-blind... | 2011-09-06 | due-trials |
Reported results | 2006-002201-31 | Long-term efficacy and safety of V0034 CR 01B cream in patients with moderate-to-severe uremic xerosis. | 2009-03-16 | due-trials |
Reported results | 2006-006878-22 | Efficacy and tolerance of Tazarotene cream in lamellar ichthyosis (LI): a dose-finding study. | 2009-04-20 | due-trials |
Reported results | 2007-000911-27 | Evaluation of the protection activity of microfine Ti02, pigmentary Ti02 and bisoctrizole and their combinations in voluntary patients with idiopathic solar urticaria (SU): phase II photoprovocation t... | 2008-04-22 | due-trials |
Reported results | 2009-011276-29 | Systemic and local diffusion of ethanol after administration of ethanol 96% formulated in a gel (L0122 Gel) and ethanol 98% solution (absolute ethanol) by the percutaneous route, in patients with cong... | 2010-06-30 | due-trials |
Listed as ongoing, but also has a completion date and reported results | 2010-022284-35 | CLINICAL EFFICACY AND SAFETY OF TAZAROTENE CREAM 0.05% IN THE INITIAL AND MAINTENANCE THERAPIES OF LAMELLAR ICHTHYOSIS (LI) | 2013-12-03 | bad-data |